C O N M E D Corp (CNMD) Stock Price, Quote & News

Company Profile

CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures in the United States and internationally. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as provides suppor...

Industry: Medical Devices

Sector: Healthcare

Phone: 727 392 6464

Website: www.conmed.com

Address:

11311 Concept Boulevard, Largo, United States

JarvisFlow Aug. 8 at 10:00 AM

Wells Fargo updates rating for Conmed ( $CNMD ) to Equal-Weight, target set at 71 → 74.

0 · Reply

Estimize Aug. 6 at 1:03 PM

Wall St is expecting 1.05 EPS for $CNMD Q3 [Reporting 10/22 AMC] http://www.estimize.com/intro/cnmd?chart=historical&metric_name=eps&utm_co

0 · Reply

ZacksResearch Jul. 31 at 6:42 PM

$CNMD beats expectations and raises 2025 guidance! 🚀 CONMED's Q2 adjusted EPS of $1.15 topped the Zacks Consensus Estimate, and revenues grew 3.1% year over year, driven by strong product momentum in BioBrace, AirSeal, and Foot & Ankle. The company now forecasts 2025 revenues up to $1.378 billion and adjusted EPS between $4.40-$4.55. Discover the full scoop here 👉 https://www.zacks.com/stock/news/2644986/conmed-q2-earnings-revenues-beat-estimates-2025-outlook-raised?cid=sm-stocktwits-2-2644986-body-5266&ADID=SYND_STOCKTWITS_TWEET_2_2644986_BODY_5266

0 · Reply

ZacksResearch Jul. 31 at 4:55 PM

$CNMD beat earnings and raised its 2025 outlook — what’s driving the upside? Q2 strength came from improving sales across both segments, pushing both earnings and revenues above estimates. Full breakdown here 👉 https://www.zacks.com/stock/news/2644986/conmed-q2-earnings-revenues-beat-estimates-2025-outlook-raised?cid=sm-stocktwits-2-2644986-teaser-5182&ADID=SYND_STOCKTWITS_TWEET_2_2644986_TEASER_5182

0 · Reply

JarvisFlow Jul. 31 at 1:56 PM

Piper Sandler updates rating for Conmed ( $CNMD ) to Overweight, target set at 80 → 68.

0 · Reply

DonCorleone77 Jul. 30 at 9:04 PM

$CNMD Conmed reports Q2 adjusted EPS $1.15, consensus $1.12 -- Q2 revenue $342.3M, consensus $338.42M. -- Cuts FY25 EPS view to $4.40-$4.55 from $4.45-$4.60, consensus $4.40 -- Narrows FY25 revenue view to $1.356B-$1.378B from $1.35B-$1.378B, consensus $1.36B.

0 · Reply

Estimize Jul. 23 at 12:07 PM

Wall St is expecting 1.12 EPS for $CNMD Q2 [Reporting 07/30 AMC] http://www.estimize.com/intro/cnmd?chart=historical&metric_name=eps&utm_co

0 · Reply

StockInsanity2025 Jul. 21 at 5:08 PM

$CNMD reasonable price target anyone?

0 · Reply

ZacksResearch Jul. 10 at 2:50 PM

$CNMD down 22.7% so far this year — is this medical player ready to bounce back? 📉 With a solid product lineup and improved margins, CONMED's 2025 outlook looks promising despite supply-chain and data security challenges. The company expects continued growth as hospital systems prioritize minimally invasive procedures. Opportunity assessment here 👉 https://www.zacks.com/stock/news/2570795/heres-why-you-should-retain-conmed-stock-in-your-portfolio-for-now?cid=sm-stocktwits-2-2570795-body-1180&ADID=SYND_STOCKTWITS_TWEET_2_2570795_BODY_1180

0 · Reply

ZacksResearch Jul. 10 at 11:43 AM

$CNMD is holding strong — here’s why it still deserves a spot in your portfolio 👇 Recurring revenues are solid, margins are improving, and surgical product growth continues — even with supply and cybersecurity headwinds. Full breakdown here 👉 https://www.zacks.com/stock/news/2570795/heres-why-you-should-retain-conmed-stock-in-your-portfolio-for-now?cid=sm-stocktwits-2-2570795-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2570795_TEASER

0 · Reply

CONMED Corporation Announces Quarterly Cash Dividend

Jul 30, 2025, 10:48 PM EDT - 12 days ago

CONMED Corporation (CNMD) Q2 2025 Earnings Call Transcript

Jul 30, 2025, 4:05 PM EDT - 12 days ago

CONMED Corporation Announces Second Quarter 2025 Financial Results

Jul 7, 2025, 5:00 PM EDT - 5 weeks ago

Martha Aronson to Step Down from CONMED Board of Directors Following Appointment as President and Chief Executive Officer of Merit Medical Systems, Inc.

Jul 2, 2025, 4:05 PM EDT - 5 weeks ago

CONMED Corporation to Announce Second Quarter 2025 Financial Results on July 30, 2025

May 21, 2025, 7:03 AM EDT - 2 months ago

CONMED Corporation Appoints LaVerne Council as Chair of the Board of Directors

Apr 30, 2025, 9:52 PM EDT - 3 months ago

CONMED Corporation (CNMD) Q1 2025 Earnings Call Transcript

Apr 30, 2025, 4:05 PM EDT - 3 months ago

CONMED Corporation Announces First Quarter 2025 Financial Results

Apr 2, 2025, 4:05 PM EDT - 4 months ago

CONMED Corporation to Announce First Quarter 2025 Financial Results on April 30, 2025

Feb 25, 2025, 7:03 AM EST - 5 months ago

CONMED Corporation Adds Mark Kaye to its Board of Directors

Feb 6, 2025, 6:57 AM EST - 6 months ago

These Analysts Slash Their Forecasts On Conmed After Q4 Results

Feb 5, 2025, 7:05 PM EST - 6 months ago

CONMED Corporation (CNMD) Q4 2024 Earnings Call Transcript

Feb 5, 2025, 4:05 PM EST - 6 months ago

CONMED Corporation Announces Fourth Quarter and Full-Year 2024 Financial Results

Jan 6, 2025, 4:16 PM EST - 7 months ago

CONMED Corporation to Announce Fourth Quarter 2024 Financial Results on February 5, 2025

Jan 2, 2025, 4:05 PM EST - 7 months ago

CONMED Corporation to Present at the J.P. Morgan Healthcare Conference

Nov 25, 2024, 8:29 AM EST - 9 months ago

Top 3 Health Care Stocks That May Dip This Month

BFLY MDGL

Nov 18, 2024, 4:05 PM EST - 9 months ago

CONMED Corporation to Participate in a Fireside Chat at the Piper Sandler Healthcare Conference

Nov 4, 2024, 4:05 PM EST - 10 months ago

CONMED Corporation to Participate in Fireside Chats at Two Investor Conferences on November 19-20

Oct 30, 2024, 9:21 PM EDT - 10 months ago

CONMED Corporation (CNMD) Q3 2024 Earnings Call Transcript

Oct 30, 2024, 4:05 PM EDT - 10 months ago

CONMED Corporation Announces Third Quarter 2024 Financial Results

Oct 30, 2024, 4:02 PM EDT - 10 months ago

CONMED Corporation Announces Leadership Succession

Oct 4, 2024, 8:00 AM EDT - 11 months ago

CONMED Corporation Announces Preliminary Third Quarter Financial Information

Sep 12, 2024, 11:21 AM EDT - 11 months ago

Carpal Tunnel Release Systems Market Forecast Report 2024-2030, Featuring Profiles of Arthrex, Conmed, Innomed, MicroAire Surgical Instruments, Resurgens Orthopaedics, S2S Surgical and Trice Medical

Sep 3, 2024, 4:05 PM EDT - 1 year ago

CONMED Corporation to Participate in a Virtual Fireside Chat at the CL King Best Ideas Conference

Aug 19, 2024, 4:05 PM EDT - 1 year ago

CONMED Corporation to Participate in a Fireside Chat at the Wells Fargo Healthcare Conference

Jul 31, 2024, 10:33 PM EDT - 1 year ago

CONMED Corporation (CNMD) Q2 2024 Earnings Call Transcript

Jul 31, 2024, 4:05 PM EDT - 1 year ago

CONMED Corporation Announces Second Quarter 2024 Financial Results

Jul 8, 2024, 4:30 PM EDT - 1 year ago

CONMED Corporation to Announce Second Quarter 2024 Financial Results on July 31, 2024

Jun 21, 2024, 2:49 PM EDT - 1 year ago

AirSeal Concerns Have Let Too Much Air Out Of Conmed's Valuation

May 23, 2024, 4:05 PM EDT - 1 year ago

CONMED Corporation to Participate in a Fireside Chat at the Jefferies Global Healthcare Conference

May 1, 2024, 4:05 PM EDT - 1 year ago

CONMED Corporation to Present at the BofA Securities Healthcare Conference

Apr 25, 2024, 1:16 AM EDT - 1 year ago

CONMED Corporation (CNMD) Q1 2024 Earnings Call Transcript

Apr 24, 2024, 4:05 PM EDT - 1 year ago

CONMED Corporation Promotes Patrick Beyer to Chief Operating Officer

Apr 24, 2024, 4:03 PM EDT - 1 year ago

CONMED Corporation Announces First Quarter 2024 Financial Results

Apr 2, 2024, 4:05 PM EDT - 1 year ago

CONMED Corporation to Announce First Quarter 2024 Financial Results on April 24, 2024

Jan 31, 2024, 9:17 PM EST - 1 year ago

CONMED Corporation (CNMD) Q4 2023 Earnings Call Transcript

Jan 31, 2024, 4:05 PM EST - 1 year ago

CONMED Corporation Announces Fourth Quarter and Full-Year 2023 Financial Results

Jan 3, 2024, 4:05 PM EST - 1 year ago

CONMED Corporation to Announce Fourth Quarter 2023 Financial Results on January 31, 2024

Oct 31, 2023, 4:05 PM EDT - 1 year ago

CONMED Corporation to Participate in Fireside Chats at Two Investor Conferences on November 14-15

Oct 28, 2023, 4:42 AM EDT - 1 year ago

Conmed: Sector Derating And A New Competitive Threat Shouldn't Overshadow A Solid Core Business

Oct 25, 2023, 8:18 PM EDT - 1 year ago

CONMED Corporation (CNMD) Q3 2023 Earnings Call Transcript

Oct 25, 2023, 4:05 PM EDT - 1 year ago

CONMED Corporation Announces Third Quarter 2023 Financial Results

Oct 4, 2023, 4:05 PM EDT - 2 years ago

CONMED Corporation to Announce Third Quarter 2023 Financial Results on October 25, 2023

Jul 26, 2023, 11:03 PM EDT - 2 years ago

CONMED Corporation (CNMD) Q2 2023 Earnings Call Transcript

Jul 26, 2023, 4:05 PM EDT - 2 years ago

CONMED Corporation Announces Second Quarter 2023 Financial Results

Jul 5, 2023, 4:05 PM EDT - 2 years ago

CONMED Corporation to Announce Second Quarter 2023 Financial Results on July 26, 2023

May 25, 2023, 4:05 PM EDT - 2 years ago

CONMED Corporation to Participate in a Fireside Chat at the Jefferies Healthcare Conference

May 19, 2023, 3:06 PM EDT - 2 years ago

Conmed: Updated Guidance Is Positive

Apr 26, 2023, 11:06 PM EDT - 2 years ago

CONMED Corporation (CNMD) Q1 2023 Earnings Call Transcript

Apr 26, 2023, 4:05 PM EDT - 2 years ago

CONMED Corporation Announces First Quarter 2023 Financial Results

JarvisFlow Aug. 8 at 10:00 AM

Wells Fargo updates rating for Conmed ( $CNMD ) to Equal-Weight, target set at 71 → 74.

0 · Reply

Estimize Aug. 6 at 1:03 PM

Wall St is expecting 1.05 EPS for $CNMD Q3 [Reporting 10/22 AMC] http://www.estimize.com/intro/cnmd?chart=historical&metric_name=eps&utm_co

0 · Reply

ZacksResearch Jul. 31 at 6:42 PM

0 · Reply

ZacksResearch Jul. 31 at 4:55 PM

0 · Reply

JarvisFlow Jul. 31 at 1:56 PM

Piper Sandler updates rating for Conmed ( $CNMD ) to Overweight, target set at 80 → 68.

0 · Reply

DonCorleone77 Jul. 30 at 9:04 PM

0 · Reply

Estimize Jul. 23 at 12:07 PM

Wall St is expecting 1.12 EPS for $CNMD Q2 [Reporting 07/30 AMC] http://www.estimize.com/intro/cnmd?chart=historical&metric_name=eps&utm_co

0 · Reply

StockInsanity2025 Jul. 21 at 5:08 PM

$CNMD reasonable price target anyone?

0 · Reply

ZacksResearch Jul. 10 at 2:50 PM

0 · Reply

ZacksResearch Jul. 10 at 11:43 AM

0 · Reply

NVDAMillionaire Jul. 9 at 1:55 PM

$CNMD Excellent article that nails exactly where CNMD stands right now. So if you want to update your CNMD knowledge or get acquainted with CNMD, this is a must read. https://beyondspx.com/article/conmed-s-growth-engine-powers-through-operational-headwinds-nyse-cnmd

0 · Reply

Estimize Jul. 8 at 12:03 PM

Wall St is expecting 1.12 EPS for $CNMD Q2 [Reporting 07/30 AMC] http://www.estimize.com/intro/cnmd?chart=historical&metric_name=eps&utm_co

0 · Reply

ISHARETRADEALERTS Jul. 7 at 9:00 PM

$CNMD Martha Aronson to Step Down from CONMED Board of Directors Following Appointment as President and Chief Executive Officer of Merit Medical Systems, Inc.

0 · Reply

transcendingaling Jun. 28 at 9:41 PM

$CNMD am I missing something here? Looks like an easy add

0 · Reply

Estimize Jun. 23 at 12:03 PM

Wall St is expecting 1.12 EPS for $CNMD Q2 [Reporting 07/23 AMC] http://www.estimize.com/intro/cnmd?chart=historical&metric_name=eps&utm_co

0 · Reply

Estimize Jun. 9 at 12:03 PM

Wall St is expecting 1.12 EPS for $CNMD Q2 [Reporting 07/23 AMC] http://www.estimize.com/intro/cnmd?chart=historical&metric_name=eps&utm_co

0 · Reply

ParkerDeckerOnline May. 16 at 4:59 PM

$CNMD

0 · Reply

Estimize May. 7 at 1:06 PM

Wall St is expecting 1.11 EPS for $CNMD Q2 [Reporting 07/23 AMC] http://www.estimize.com/intro/cnmd?chart=historical&metric_name=eps&utm_co

0 · Reply

BuyBrett May. 2 at 4:04 PM

$AEHL breakout coming here people get ready $WHLR $WULF $NDRA $CNMD

0 · Reply

JarvisFlow May. 1 at 3:29 PM

Wells Fargo updates rating for Conmed ( $CNMD ) to Equal-Weight, target set at 70 → 57.

0 · Reply

anachartanalyst May. 1 at 2:02 PM

$CNMD https://anachart.com/wp-content/uploads/ana_temp/1746108131_soc-img.jpg

0 · Reply

Market Cap	1.69B
Revenue (ttm)	1.31B
Net Income (ttm)	132.42M
EPS (ttm)	N/A
PE Ratio	11.89
Forward PE	11.98
Profit Margin	10.13%
Debt to Equity Ratio	0.88

Volume	817,300
Avg Vol	480,918
Day's Range	N/A - N/A
Shares Out	30.96M
Stochastic %K	50%
Beta	1.17
Analysts	Sell
Price Target	$61.00